investor presentation
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong Q4 and full year FY26 results with consolidated revenues of INR 9,128 Cr, up 17.3% YoY, and Operating EBITDA of INR 2,085 Cr, up 31.3% YoY. Operating EBITDA margins expanded to 22.8% vs 20.4% in FY25. PAT grew 31.5% to INR 1,064 Cr. The hospital business contributed 85% of revenues at INR 7,773 Cr with 19.1% growth and margin improvement to 22.2%. Diagnostics (Agilus) grew revenues 8.5% to INR 1,527 Cr with margins expanding sharply to 23.6% from 17.7%. The company completed acquisitions adding ~500 beds (People Tree Bengaluru, Shrimann Jalandhar), signed a lease for Greater Noida (~200 beds), and an O&M for a 550-bed greenfield in Lucknow. Net debt rose to INR 2,334 Cr (Net Debt/EBITDA 1.09x vs 0.93x) due to acquisitions. The Board recommended dividend of INR 1 per share. The company plans to add ~1,800 beds organically from FY27-FY30.
Strong operational performance with margin expansion reflects improving business quality. The debt-funded acquisition strategy adds bed capacity in key geographies but increases leverage. The dividend and multi-year expansion roadmap are positive for shareholders, though rising debt levels warrant monitoring.